Literature DB >> 19748724

Molecular mechanisms of functional rescue mediated by P53 tumor suppressor mutations.

Yu-Hong Tan1, Y Morris Chen, Xiang Ye, Qiang Lu, Vira Tretyachenko-Ladokhina, Wei Yang, Donald F Senear, Ray Luo.   

Abstract

We have utilized both molecular dynamics simulations and solution biophysical measurements to investigate the rescue mechanism of mutation N235K, which plays a key role in the recently identified global suppressor motif of K235/Y239/R240 in the human p53 DNA-binding domain (DBD). Previous genetic analysis indicates that N235K alone rescues five out of six destabilized cancer mutants. However, the solution biophysical measurement shows that N235K generates only a slight increase to the stability of DBD, implying a rescue mechanism that is not a simple additive contribution to thermodynamic stability. Our molecular simulations show that the N235K substitution generates two non-native salt bridges with residues D186 and E198. We find that the nonnative salt bridges, D186-K235 and E198-K235, and a native salt bridge, E171-R249, are mutually exclusive, thus resulting in only a marginal increase in stability as compared to the wild type protein. When a destabilized V157F is paired with N235K, the native salt bridge E171-R249 is retained. In this context, the non-native salt bridges, D186-K235 and E198-K235, produce a net increase in stability as compared to V157F alone. A similar rescue mechanism may explain how N235K stabilize other highly unstable beta-sandwich cancer mutants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748724      PMCID: PMC2794655          DOI: 10.1016/j.bpc.2009.08.008

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  34 in total

1.  Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.

Authors:  P V Nikolova; K B Wong; B DeDecker; J Henckel; A R Fersht
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Structural basis for p53 binding-induced DNA bending.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  J Biol Chem       Date:  2006-11-03       Impact factor: 5.157

3.  Structure of the human p53 core domain in the absence of DNA.

Authors:  Ying Wang; Anja Rosengarth; Hartmut Luecke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-02-21

4.  Molecular dynamics simulations of p53 DNA-binding domain.

Authors:  Qiang Lu; Yu-Hong Tan; Ray Luo
Journal:  J Phys Chem B       Date:  2007-09-08       Impact factor: 2.991

5.  Dimerization of the core domain of the p53 family: a computational study.

Authors:  Arumugam Madhumalar; Lee Hui Jun; David P Lane; Chandra S Verma
Journal:  Cell Cycle       Date:  2009-01-01       Impact factor: 4.534

6.  Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Authors:  A N Bullock; J Henckel; A R Fersht
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

7.  p53-Induced DNA bending: the interplay between p53-DNA and p53-p53 interactions.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2008-05-08       Impact factor: 2.991

8.  Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution.

Authors:  Chao Tu; Yu Hong Tan; Gary Shaw; Zheng Zhou; Yawen Bai; Ray Luo; Xinhua Ji
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-04-19

9.  Stability of the core domain of p53: insights from computer simulations.

Authors:  Arumugam Madhumalar; Derek John Smith; Chandra Verma
Journal:  BMC Bioinformatics       Date:  2008       Impact factor: 3.169

10.  Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements.

Authors:  Buyong Ma; Arnold J Levine
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

View more
  6 in total

1.  Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.

Authors:  Sara Calhoun; Valerie Daggett
Journal:  Biochemistry       Date:  2011-05-17       Impact factor: 3.162

2.  Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.

Authors:  Nicholas G Brown; Jeanine M Pennington; Wanzhi Huang; Tulin Ayvaz; Timothy Palzkill
Journal:  J Mol Biol       Date:  2010-10-16       Impact factor: 5.469

3.  Aggregation tendencies in the p53 family are modulated by backbone hydrogen bonds.

Authors:  Elio A Cino; Iaci N Soares; Murilo M Pedrote; Guilherme A P de Oliveira; Jerson L Silva
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

Review 4.  Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting.

Authors:  Yaw Sing Tan; Yasmina Mhoumadi; Chandra S Verma
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

5.  A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.

Authors:  M A Warso; J M Richards; D Mehta; K Christov; C Schaeffer; L Rae Bressler; T Yamada; D Majumdar; S A Kennedy; C W Beattie; T K Das Gupta
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

6.  Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.

Authors:  Suryani Lukman; David P Lane; Chandra S Verma
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.